pharmaceuticals

pharmaceuticals Articles

Johnson & Johnson is set to report its second-quarter financial results before the markets open on Tuesday.
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
JetBlue orders planes from Airbus, Pfizer to defer some drug price increases, Toyota launches car-sharing service in Hawaii, and other important business headlines.
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates in July.
Merck shares retreated to start off the week despite the announcement of good news from the FDA.
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Aquinox Pharmaceuticals saw its shares crash on Wednesday after the firm gave a disappointing update for a late-stage trial.
Infinity Pharmaceuticals shares made a healthy gain early on Tuesday after the firm announced a clinical collaboration with Arcus Biosciences.
Merrimack Pharmaceuticals shares were absolutely getting crushed on Monday after the firm gave an update from its midstage pancreatic cancer study.
Pfizer shares slipped slightly on Monday morning after the firm announced results from its late-stage trial of breast cancer. Ultimately the results were positive but not exactly what the study was...
Here, 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week and the rest of June.
Foundation Medicine shares saw a sizable jump early on Tuesday after the company announced that Roche would be acquiring all of the outstanding shares.
Analysts at Jefferies have come up with a list of four pharmaceuticals stocks that may be good investments for a time of uncertainty in global markets.
Merck & Co., Inc. (NYSE: MRK) shares took a small step back on Thursday after the company announced a key approval from the U.S. Food and Drug Administration. The agency has now approved Keytruda...
Albiero Pharma, Inc. (NASDAQ: ALBO) recently received some positive news from the U.S. Food and Drug Administration (FDA) and it could have huge implications for the stock. One analyst actually sees...